Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity (Q38615394)

4 September 2017

title

Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity (English)

1 reference

4 September 2017

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497530%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Marjolein van Egmond

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497530%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Jantine E Bakema

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497530%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

1 November 2015

1 reference

4 September 2017

published in

Immunological Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497530%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

268

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497530%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497530%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

311-327

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497530%20AND%20SRC:MED&resulttype=core&format=json

Control of adaptive immunity by the innate immune system

5 June 2020

cites work

1 reference

Innate immune recognition

21 January 2018

1 reference

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

Pattern recognition receptors and inflammation

21 January 2018

1 reference

Fcgamma receptors: old friends and new family members

21 January 2018

1 reference

IgG subclasses and allotypes: from structure to effector functions

21 January 2018

1 reference

21 January 2018

1 reference

Regulation of allergy by Fc receptors.

21 January 2018

1 reference

Properties of mouse and human IgG receptors and their contribution to disease models

21 January 2018

1 reference

Toll-like receptors: Activation, signalling and transcriptional modulation.

21 January 2018

1 reference

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

21 January 2018

1 reference

Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways

21 January 2018

1 reference

Human TLR10 is an anti-inflammatory pattern-recognition receptor

21 January 2018

1 reference

MyD88: a central player in innate immune signaling

21 January 2018

1 reference

TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk.

21 January 2018

1 reference

Antibody-mediated modulation of immune responses.

21 January 2018

1 reference

Primary immunodeficiency disorders: antibody deficiency

21 January 2018

1 reference

Identification of a family of Fc receptor homologs with preferential B cell expression

21 January 2018

1 reference

Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG.

21 January 2018

1 reference

The biology of IGE and the basis of allergic disease

21 January 2018

1 reference

Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

21 January 2018

1 reference

Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential

21 January 2018

1 reference

Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells.

21 January 2018

1 reference

TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved

21 January 2018

1 reference

Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21.

21 January 2018

1 reference

Novel roles for the IgG Fc glycan

21 January 2018

1 reference

Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses

21 January 2018

1 reference

The physiological role of DC-SIGN: a tale of mice and men.

21 January 2018

1 reference

General mechanism for modulating immunoglobulin effector function

21 January 2018

1 reference

Inhibitory ITAMs as novel regulators of immunity.

21 January 2018

1 reference

How ITAMs inhibit signaling

21 January 2018

1 reference

IgG opsonization of bacteria promotes Th17 responses via synergy between TLRs and FcγRIIa in human dendritic cells.

21 January 2018

1 reference

Antibody-opsonized bacteria evoke an inflammatory dendritic cell phenotype and polyfunctional Th cells by cross-talk between TLRs and FcRs

21 January 2018

1 reference

Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity

21 January 2018

1 reference

Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages

21 January 2018

1 reference

FcγRIIa cross-talk with TLRs, IL-1R, and IFNγR selectively modulates cytokine production in human myeloid cells

21 January 2018

1 reference

Differential TLR-induced cytokine production by human mast cells is amplified by FcɛRI triggering.

21 January 2018

1 reference

Activation of human basophils by combined toll-like receptor- and FcεRI-triggering can promote Th2 skewing of naive T helper cells

21 January 2018

1 reference

Immunobiology of dendritic cells

21 January 2018

1 reference

Innate signaling and regulation of Dendritic cell immunity

21 January 2018

1 reference

Induction, function and regulation of IL-17-producing T cells

21 January 2018

1 reference

Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4.

21 January 2018

1 reference

The inflammasomes: guardians of the body

21 January 2018

1 reference

Signaling in innate immunity and inflammation

21 January 2018

1 reference

Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors.

21 January 2018

1 reference

Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways

21 January 2018

1 reference

Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages

21 January 2018

1 reference

Fungal Recognition by TLR2 and Dectin-1.

21 January 2018

1 reference

C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB

21 January 2018

1 reference

Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?

21 January 2018

1 reference

Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes

21 January 2018

1 reference

Role of TREM-1 in response to Aspergillus fumigatus infection in corneal epithelial cells

21 January 2018

1 reference

A role for the ITAM signaling module in specifying cytokine-receptor functions

21 January 2018

1 reference

Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases

21 January 2018

1 reference

Human inflammatory dendritic cells induce Th17 cell differentiation.

21 January 2018

1 reference

Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity

21 January 2018

1 reference

Initial immunopathogenesis of multiple sclerosis: innate immune response.

21 January 2018

1 reference

The role of antibodies in multiple sclerosis

21 January 2018

1 reference

Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

21 January 2018

1 reference

The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.

21 January 2018

1 reference

The role of innate immune responses in autoimmune disease development

21 January 2018

1 reference

Evaluating the role of Toll-like receptors in diseases of the central nervous system

21 January 2018

1 reference

Role of IgG Fc Receptors in Monoclonal Antibody Therapy of Cancer

21 January 2018

1 reference

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.

21 January 2018

1 reference

Combination strategies to enhance antitumor ADCC.

21 January 2018

1 reference

Immunoglobulin A: A next generation of therapeutic antibodies?

21 January 2018

1 reference

Myeloid cells as effector cells for monoclonal antibody therapy of cancer.

21 January 2018

1 reference

Macrophages eliminate circulating tumor cells after monoclonal antibody therapy

21 January 2018

1 reference

Natural killer (NK): dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity

21 January 2018

1 reference

Natural innate and adaptive immunity to cancer

21 January 2018

1 reference

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

21 January 2018

1 reference

Toll-like receptor agonists: are they good adjuvants?

21 January 2018

1 reference

New developments in Toll-like receptor targeted therapeutics.

21 January 2018

1 reference

Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells

21 January 2018

1 reference

Trial Watch: Toll-like receptor agonists in oncological indications

21 January 2018

1 reference

CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells

21 January 2018

1 reference

TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR(+) head and neck cancer cells.

21 January 2018

1 reference

TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells

21 January 2018

1 reference

Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy

21 January 2018

1 reference

TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy

21 January 2018

1 reference

Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies

21 January 2018

1 reference

Inhibitory ITAM Signaling Traps Activating Receptors with the Phosphatase SHP-1 to Form Polarized "Inhibisome" Clusters

21 January 2018

1 reference

IgG1 and IVIg induce inhibitory ITAM signaling through Fc RIII controlling inflammatory responses

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/IMR.12333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26497530%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference